Immupharma annual free cash flow
2022
2024
2025
Immupharma Free Cash Flow (FCF) History (IMM)
Immupharma reported −£2.4M in free cash flow for fiscal 2025, a decrease of £603,272 from the previous fiscal year.
View full Immupharma company overviewImmupharma free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −£2.4M | −£603,272 | — | — |
| 2024 | 2024-12-31 | −£1.8M | — | — | — |
| 2022 | 2022-12-31 | −£2.5M | — | — | — |
Immupharma free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Immupharma source filings ↗